Inhalation of H2/O2 (66.7 %/33.3 %) mitigates depression-like behaviors in diabetes mellitus complicated with depression mice via suppressing inflammation and preventing hippocampal damage

• Published in: Biomedicine & pharmacotherapy 2024-11, Vol.180, p.117559, Article 117559
• Main Authors: Fan, Huaju, Shi, Yanhua, Liu, Haiqiang, Zuo, Xiaofei, Yang, Yanmei, Yin, Hao, Li, Yanyan, Wang, Xianghui, Liu, Li, Wang, Fengjiao, Han, Huifang, Wu, Qianying, Yang, Nana, Tang, Yaohui, Lu, Guohua
• Format: Article
• Language: English
• Subjects: Depression; Diabetes mellitus; Hippocampus; Hydrogen; Inflammation
• ISSN: 0753-3322; 1950-6007; 1950-6007
• DOI: 10.1016/j.biopha.2024.117559

Diabetes mellitus complicated with depression (DD) is a prevalent psychosomatic disorder. It is characterized by severe cognitive impairment, and associated with high rates of disability and mortality. Although conventional treatment options are available, the efficacy of these regimens in managing DD remains limited. Molecular hydrogen (H2), a selective hydroxyl radical scavenger, has shown therapeutic potential in the treatment of various systemic diseases. This study aims to investigate the therapeutic effects of H2 on DD. A DD mouse model was established through intraperitoneal injection of streptozotocin (STZ, 150 mg/kg) and lipopolysaccharide (LPS, 0.5 mg/kg). Following the induction of DD, the mice were treated with H2/O2 (66.7 %/33.3 %)inhalation for 7 days. Behavioral assessments were conducted by standard behavioral tests, and the levels of inflammatory cytokines in peripheral blood serum and hippocampal tissue were measured using enzyme-linked immunosorbent assay (ELISA). Furthermore, magnetic resonance imaging (MRI) scans and immunofluorescence staining of the hippocampus were performed to evaluate hippocampal structural integrity. The results demonstrated that inhalation of H2/O2 (66.7 %/33.3 %) significantly ameliorated depressive behaviors and symptoms in DD mice, reversed hippocampal volume reduction, decreased inflammatory cytokine levels in peripheral blood serum and hippocampal tissue, and inhibited the activation of A1 astrocytes in the hippocampus. Our study suggests that H2/O2 (66.7 %/33.3 %) inhalation therapy may offer a promising treatment strategy for DD and its associated symptoms. [Display omitted] •DD mouse model can be established through intraperitoneal injection of STZ and LPS.•Peripheral inflammation and hippocampal damage are associated with DD.•H2/O2 (66.7 %/33.3 %) inhalation therapy shows significant therapeutic effects on DD.